Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Biological Effect of Tarceva (OSI-774) for Patients Stricken by ENT Epidermoid Carcinoma

This study has been completed.
Roche Pharma AG
Information provided by:
Institut Claudius Regaud Identifier:
First received: September 2, 2005
Last updated: March 26, 2015
Last verified: May 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2006
  Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)